CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (NASDAQ: CERS - News) announced today that Carol M. Moore has been appointed vice president, regulatory affairs and quality. In that position, Ms. Moore will be responsible for implementing global strategies for registration and regulatory compliance and with maintaining ISO quality standards related to the INTERCEPT Blood System.
